|
|
||||||||
Edward Mallinckrodt Department of Pediatrics and the Department of Neurological Surgery and Neurology (Neurology) and the Division of Clinical Neuropharmacology, Washington University School of Medicine, and the Division of Pediatric Neurology. St. Louis Children's Hospital, St. Louis, MO.
The nonlinear kinetics of phenytoin were evaluated in 54 children by measuring phenytoin concentrations at steady state at three or more doses. There was good correlation between phenytoin doses and concentrations when a nonlinear kinetic model was used (r = 0.896). Increasing age was associated with a reduction in the apparent Vmax. The apparent Km was influenced primarily by drug interactions. Phenobarbital increased the Km and Vmaxfor phenytoin. Carbamazepine reduced both Km and Vmax. Valproic acid reduced the Km. The low Km (< 2.6 mg per liter) found in 28% of patients makes titration of the phenytoin dose to therapeutic levels difficult.
Address correspondence and reprint requests to Dr. Dodson, St. Louis Children's Hospital. 500 South Kings highway, P.O. Box 14871, St. Louis, MO 63178.
This work was supported by grants from the National Foundation-March of Dimes; Public Health Service Research Grant No. RR-36 from the General Clinical Research Center Branch; NIH Mass Spectrometry Resource Grant No. RR-00954; and NIH Career Academic Development Award No. 1-K07 NS11074.
Accepted for publication June 17, 1981.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |